An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close contact with someone who is infected vulnerable to developing COVID ...

In the large clinical trials that proved the benefits of statins, about a quarter of people complained of myalgia, although ...

An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed ...

The global HIV drugs industry was valued at USD 28.6 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to ...